FRANCE — French drugmaker Sanofi has agreed to acquire US-based pharmaceutical firm Provention Bio for approximately US$2.9 billion to strengthen its general medicines portfolio with the US-approved type 1 diabetes…
Read MoreTag: France
Clean Cells begins activities in the largest biopharmaceutical testing site in Europe
FRANCE – Clean Cells has launched analytical activities at its €22 million (US$24.1m) new facility based in Montaigu-Vendée. Clean Cells is part of the Clean Biologics group, a provider of…
Read MoreSanofi’s global head of R&D leaves for a similar role at J&J
FRANCE — Sanofi’s global head of R&D, John Reed has stepped down from his role in the company to join Johnson & Johnson, where he’ll serve as executive vice president…
Read MoreSanofi and Regeneron’s Dupixent wins new European Commission approval for atopic dermatitis in children
FRANCE — The European Union’s medicines regulator has given a new stage of approval for Dupixent, Sanofi, and Regeneron’s product to treat children as young as 6 months old with…
Read MoreSanofi seeks to launch Hemophilia A drug this year — CNBC
FRANCE — French drugmaker Sanofi SA plans to launch a drug for rare bleeding disorder hemophilia A this year, Chief Executive Officer Paul Hudson told CNBC in an interview. The…
Read MoreEveImmune’s oncobiotic drug candidate treats first cancer patient in Phase I clinical trial
FRANCE — EverImmune, a clinical-stage biotech company specializing in the development of live biotherapeutics in microbiota oncology, reports that the first patient has been treated in Phase I clinical trial…
Read MoreFrance suspends internet sales of paracetamol over shortage fears
FRANCE — The French government has announced an immediate ban on the internet sale of all paracetamol-based painkillers, effective until the end of January. Paracetamol, particularly in forms suitable for…
Read MoreIpsen acquires Albireo Pharma bolstering its rare disease portfolio, pipeline
FRANCE — Ipsen and Albireo have agreed to merge, with Ipsen acquiring Albireo, a rare disease company focused on the development of bile acid modulators for the treatment of pediatric…
Read MoreFrench hospital hit by cyberattack, cancels operations
FRANCE — A hospital in Versailles, near Paris had to cancel operations and transfer some patients after being hit by a cyberattack over the weekend, France’s health ministry has said.…
Read MoreQuest for health accelerator launches in French Grand Est region with focus on healthcare start-ups
FRANCE — Quest for change, a French regionally-certified network of five high-quality incubators (Innovact, Quai Alpha, Rimbaud’Tech, SEMIA, and The Pool), based in six locations within the Grand Est region,…
Read More